1-3 of 3
bosnia-herzegovina
Close
Sort by
Journal Articles

The Comparison of Efficacy Between Generic and Branded Imatinib in Achievement of Overall Survival and Cytogenetic Responses in CML Patients in Bosnia and Herzegovina

Amina Kurtovic Kozaric, PhD, Erna Islamagic, Jerald P. Radich, MD, Emina Suljovic Hadzimesic, MD MA, Azra Hasic, MBBS, MA, Sabira Kurtovic, MD
Journal: Blood
Blood (2016) 128 (22): 5451.
https://doi.org/10.1182/blood.V128.22.5451.5451
Published: 2016
Journal Articles

Hb F Malta I in Association with Hb F Sardinia (AyT) and Hb Valletta in Heterozygotes: Quantification of the Six Globins Suggests Developmental Control of the XMN-I Site and Interplay with the (AT)xTy Sequence in Connection with Globin Gene Switching.

Alexander Felice, MD, PhD, Joseph Borg, B.Sc., Wilma Cassar, B.Pharm., Ruth Galdies, B.Pharm., Monica Pizzuto, M.Sc., Maryrose Caruana, R.N., Christian Scerri, M.D., Ph.D
Journal: Blood
Blood (2006) 108 (11): 3830.
https://doi.org/10.1182/blood.V108.11.3830.3830
Published: 2006
Journal Articles

Down-Regulation of Activin A by Lymphoma: A Possible Mechanism of Bone Marrow Involvement.

Michal Z. Haran, MD, Reshmi Parameswaran, Edit Feldberg, MD, Mina Fogel, PhD, Monica Huszar, MD, Alain Berrebi, MD, Mordechai Shtalrid, MD, Lev Shvidel, MD, Adrian Duek, MD, Merav Leiba, PhD, Arnon Nagler, MD, Dov Zipori, PhD
Journal: Blood
Blood (2005) 106 (11): 4669.
https://doi.org/10.1182/blood.V106.11.4669.4669
Published: 2005